Executive Director and Head of the Regulatory Centers of Excellence
Seagen Inc.
Linda joined the BioPharma industry in 1983 and has spent the last 30 years in regulatory strategy, intelligence and policy roles. She is Executive Director, Head of the Regulatory Centers of Excellence at Seagen Inc. and for the last 25 years has been an Assistant Adjunct Professor in the Temple University RAQA graduate program. She attained Regulatory Affairs Certification for the US, Canada and Europe and was an inductee to the 2011 Class of RAPS Fellows. Linda was honored with the RAPS 2020 Founder's Award as well as the Drug Information Association 2012 and 2019 Excellence in Volunteer Leadership Awards and the 2022 Global Inspire Award for Community Engagement.
She is a past two-term member of the RAPS Board of Directors, current Chair of the RAPS Affiliate Board, and former Chair of the NJ/NY RAPS Chapter. She sat on the planning committee for multiple DIA and RAPS Conferences and was Program Chair for the 2018 and 2019 RAPS Annual Convergence. She is a frequent author and speaker on regulatory topics and volunteers her time providing regulatory education and mentoring to PhD and Postdoctoral bench researchers at leading US medical schools.
Disclosure information not submitted.
The Future of Regulatory Affairs In An Everchanging World
Wednesday, October 4, 2023
3:30 PM – 4:30 PM EDT